Sana Biotechnology

reshuffle pipeline target reorganize shift change
Biotech

Sana, CAMP4 ditch clinical-stage assets for preclinical hopefuls

Sana, CAMP4 and Crinetics have used the third quarter to refocus their pipelines on the most promising candidates.
James Waldron Nov 7, 2025 8:13am
gold arrow pointing upward forward

Sana stock price triples after allogeneic cell therapy data drop

Jan 8, 2025 10:38am
team funding workforce workforce reductions cash runway

Sana strips back cancer, CNS programs while warning of layoffs

Nov 5, 2024 7:05am
Paragliding with Mount Rainier in the background

Cell-focused Sana scoops first CSO—Chutes & Ladders

Aug 30, 2024 8:30am
Small white blocks with black text that say Diabetes Type 1 in all caps surrounded by syringes containing a blue liquid th

Sana's engineered islet cells control glucose in diabetic monkey

Feb 15, 2024 2:55pm
quit fire layoff workforce reduction exit

Sana retreats from in vivo CAR-T delivery, lays off 29% of staff

Oct 11, 2023 5:00am